[Immunologic reactivity of the skin in chronic hepatitis]. 1990

H Fuchs
Kliniki Endokrynologii i Chorób Przemiany Materii Instytutu Chorób Wewnetrznych Pomorskiej Akademii Medycznej.

The aim of the study was to evaluate the practical usefulness of immunological examination of the skin in chronic liver diseases, especially chronic active hepatitis (CAH) HBsAg (+). Fifty-four patients were examined. DNCB and tuberculin skin tests as well as direct immunofluorescence method for clinically normal skin specimens were used to estimate some of the immunological processes in the skin. Results of immunopathological examinations of the skin in a group of patients with CAH HBsAg (+) were compared with some clinical, biochemical and serological data. The skin delayed hypersensitivity tests with DNCB and tuberculin were negative in the majority of persons having CAH HBsAg (+), which provided support for the cellular immunity discrimination in these cases. It was demonstrated that serum HBsAg titer in patients with CAH HBsAg (+) and positive tuberculin test was significantly lower as compared to the group with negative tuberculin test. Deposits of immunoglobulins, particularly IgM, and C3-component of complement in vessel walls were stated in clinically normal skin in patients with CAH HBsAg (+) and other liver diseases. They were found in about 3/4 of the examined cases of CAH HBsAg (+). C3-deposits were recorded significantly more frequently in superficial skin vessel walls in patients with histologically diagnosed liver cirrhosis. It seems that homogenous deposits of IgM or C3 in skin vessel walls may indicate early and granular--later stage of CAH HBsAg (+). Immunological examinations of the skin may be useful for better evaluating the cases of chronic liver diseases, particularly in chronic active hepatitis with HBs-antigenaemia.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Fuchs
September 1979, Casopis lekaru ceskych,
H Fuchs
April 1975, Annals of the New York Academy of Sciences,
H Fuchs
August 1975, Monatsschrift fur Kinderheilkunde,
H Fuchs
January 1961, Studii si cercetari de medicina interna,
H Fuchs
August 1988, Casopis lekaru ceskych,
H Fuchs
June 1969, American journal of obstetrics and gynecology,
H Fuchs
January 1984, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
H Fuchs
March 1986, Gematologiia i transfuziologiia,
H Fuchs
January 1972, Grudnaia khirurgiia (Moscow, Russia),
Copied contents to your clipboard!